Subventions et bourses 2016

GRANTS IN AID OF RESEARCH

Dr. Wallace MacNaughton

(Co-investigator: Dr. Paul Beck)

University of Calgary

How PAR2 regulates death of epithelial cells that line the intestine and turns off inflammation

$371,460

(2014-2017)

Dr. Andre Buret

(Co-investigators: Drs. Hans Vogel, Joe Harrison, Paul Beck)

University of Calgary

How microbiota biofilms cause post-infectious flare-ups in IBD

$371,460

(2014-2017)

Dr. Simon Hirota

(Co-investigator: Dr. Thomas Chang)

University of Calgary

How PXR keeps the inner lining of the gut tight and protects against the damaging effects of inflammation

$370,930

(2014-2017)

Dr. Kris Chadee

University of Calgary

How mucin prevents gut microbes and toxins from directly interacting with the underlying gut epithelium

$371,460

(2014-2017)

Dr. Aleixo Muise

(Co-investigator: Dr. Daniella Rotin)

The Hospital for Sick Children

How certain genes help control the leakiness of the bowel in IBD

$371,460

(2014-2017)

Dr. Mark Lathrop

(Co-investigator: Dr. Tomi Pastinen)

McGill University

Use high-tech sequencing platform to uncover new types of high-risk genetic risk factors in IBD

$371,460

(2014-2017)

Dr. Brian Coombes

McMaster University

How E. coli infection is linked to post-infectious IBS and IBD

$220,110

(2014-2017)

Dr. Dean Tripp

(Co-investigator: Dr. Mike Beyak)

Queen’s University

Understanding and improving the psychosocial risk factors of IBD pain and poorer quality of life

$268,620

(2014-2017)

Dr. Eric Benchimol

(Co-investigators: Drs. Harminder Singh, Anthony Otley, Anne Griffiths, Geoffrey Nguyen, Matthew Carroll, Alain Bitton)

Children’s Hospital of Eastern Ontario

Describe variation of how and when care is being provided in Canadian children with IBD

$369,560

(2014-2017)

INNOVATIONS IN IBD GRANTS

Dr. Charles Bernstein

(Co-investigators: Drs. Laura Targownik, Hillary Steinhart, John Marshall)

University of Manitoba

Denosumab for the treatment of Crohn’s disease

$50,000

(2014-2015)

Dr. Stephen Girardin

(Co-investigator: Dr. David Prescott)

University of Toronto

Targeted genome editing in human intestinal epithelial cells

$50,000

(2014-2015)

Dr. Andrew Stadnyk

(Co-investigator: Dr. Anthony Otley)

IWK 
Health Centre

An innovative approach to cell therapy for Crohn’s disease

$50,000

(2014-2015)

Dr. Stuart Turvey

(Co-investigators: Drs. Laura Sly, Hong Yang)

University of
British Columbia

Development of anti-inflammatory nanomedicine for inflammatory bowel disease

$50,000

(2014-2015)

  • Les taux de ces maladies au Canada figurent parmi les plus élevés du monde.
  • 1 CANADIEN SUR 150 VIT AVEC LA MALADIE DE CROHN OU LA COLITE
  • Pour la première fois, les familles nouvellement arrivées au Canada contractent la maladie de Crohn et la colite
  • Depuis 1995, l’incidence de la maladie de Crohn chez les enfants canadiens de 10 ans et moins a presque doublé
  • Les gens sont le plus souvent diagnostiqué avant 30 ans.